Notice of Meeting, 44894-44895 [2020-16030]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES 44894 Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices Certification Organizations (COs) Question 21: What benefits and risks would COs provide to IDIs, third parties, and consumers? Question 22: To what extent would COs be effective in assessing compliance with applicable standards in an environment with rapidly developing technology systems, products, and platforms, especially given the potential need to reassess and reevaluate such systems, products, and platforms as technologies or circumstances change? Question 23: For model validation and testing, would COs evaluate a model based solely on reports, testing results, and other data provided by the third-party provider of the model? Or would the COs need to test the model and generate their own test results? What steps would the COs need to take to protect the intellectual property or other sensitive business data of the third party that has submitted its model to the validation process? Question 24: If COs receives derogatory information indicating that a certified third party or certified model or technology no longer meets applicable standards, should the COs develop a process for withdrawing a certification or reassessing the certification? (1) If so, what appeal rights should be available to the affected third party? (2) What notification requirements should COs have for financial institutions that have relied on a certification that was subsequently withdrawn? (3) Should the FDIC or Federal/state regulators enter information sharing agreements with COs to ensure that any derogatory information related to a certified third party or certified model or technology is appropriately shared with the COs? Question 25: Are there legal impediments, including issues related to liability or indemnification, to the implementation of a voluntary certification program that the FDIC, other Federal/state regulators, thirdparty providers, and IDIs should consider? Question 26: To what extent should the FDIC and other Federal/state regulators play a role, if any, in the identification and oversight of COs, including assessments of ongoing operations? Should the FDIC and other Federal/state regulators provide oversight of COs, or should another entity, such as an SSO, provide such oversight? Federal Deposit Insurance Corporation. VerDate Sep<11>2014 20:45 Jul 23, 2020 Jkt 250001 Dated at Washington, DC, on July 21, 2020. James P. Sheesley, Acting Assistant Executive Secretary. Authority: Section 494 of the Energy Independence and Security Act of 2007 (EISA, 42 U.S.C. 17123). [FR Doc. 2020–16058 Filed 7–23–20; 8:45 am] Kevin Kampschroer, Federal Director, Office of Federal HighPerformance Buildings, General Services Administration. BILLING CODE 6714–01–P [FR Doc. 2020–16067 Filed 7–23–20; 8:45 am] GENERAL SERVICES ADMINISTRATION BILLING CODE 6820–14–P [Notice–MG–2020–04; Docket No. 2020– 0002; Sequence No. 24] DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Federal High-Performance Buildings; Green Building Advisory Committee; Updated Notification Extending Conference Calls Agency for Healthcare Research and Quality Office of Government-Wide Policy, General Services Administration (GSA). AGENCY: Updated notice extending biweekly conference calls. ACTION: The General Services Administration (GSA) Office of Federal High-Performance Buildings within the Office of Government-wide Policy is announcing an amendment to notice Notice–MG–2020–02, dated January 15, 2020. The recurring, biweekly conference calls of the Green Building Advisory Committee’s Embodied Energy Task Group will now be extended to last through November 18, 2020. SUMMARY: The recurring, biweekly conference calls of the Green Building Advisory Committee’s Embodied Energy Task Group will continue on Wednesdays from 1:00 p.m. to 2:00 p.m., ET through November 18, 2020. DATES: Mr. Michael Bloom, Office of Federal HighPerformance Buildings, Office of Government-wide Policy, General Services Administration, 1800 F Street NW, (Mail-code: MG), Washington, DC 20405, at 312–805–6799 or at michael.bloom@gsa.gov. Additional information about the Committee is available on-line at http://www.gsa.gov/ gbac. FOR FURTHER INFORMATION CONTACT: NoticeMG–2020–02, published at 85 FR 2425 (January 15, 2020). SUPPLEMENTARY INFORMATION: Procedures for Attendance Contact Mr. Michael Bloom at michael.bloom@gsa.gov to register to attend the remaining conference calls. To attend, submit your full name, organization, email address, and phone number. Requests to attend must be received by 5:00 p.m., ET, on August 3, 2020. PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Notice of Meeting Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on ‘‘COVID–19 REVISION SUPPLEMENT APPLICATION ZHS1 HSR–0 (03) HEALTHCARE SYSTEMS & VALUE RESEARCH (HSVR).’’ This SEP meeting will be closed to the public. DATES: August 7, 2020. ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20850. FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427–1557. SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly-scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘COVID–19 REVISION SUPPLEMENT APPLICATION ZHS1 HSR–0 (03) HEALTHCARE SYSTEMS & VALUE SUMMARY: E:\FR\FM\24JYN1.SGM 24JYN1 44895 Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices RESEARCH (HSVR)’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for this meeting are subject to change as priorities dictate. Dated: July 20, 2020. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2020–16030 Filed 7–23–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Expedited OMB Review and Public Comment; Proposed Information Collection Activity; Release of Unaccompanied Alien Children From ORR Custody Office of Refugee Resettlement; Administration for Children and Families; HHS. AGENCY: ACTION: Request for public comment. The Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is requesting expedited review of an information collection request from the Office of Management and Budget (OMB) and inviting public comments on the proposed collection. The request consists of several forms that allow the Unaccompanied Alien Children (UAC) Program to process release of UAC from ORR custody and provide services after release. DATES: Comments due within 60 days of publication. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described in this notice. ADDRESSES: Copies of the proposed collection of information can be obtained and comments may be forwarded by emailing infocollection@ acf.hhs.gov. Alternatively, copies can also be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation (OPRE), 330 C Street SW, Washington, DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or written, should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: ACF is requesting that OMB grant a 180 day approval for this request under procedures for expedited SUMMARY: processing. Any edits resulting from public comment will be incorporated into the submission under normal procedures. The components of this information request include: 1. Discharge Notification (Form R–2): This instrument is used by care provider facilities to notify stakeholders of the transfer of a UAC to another care provider facility or the release of a UAC from ORR custody. 2. Notice to Immigration and Customs Enforcement (ICE) Chief Counsel— Release of Unaccompanied Alien Child to Sponsor and Request to Change Address (Form R–3): This instrument is used by care provider facilities to notify ICE Chief Counsel of the release of a UAC and request a change of address. 3. Release Request (Form R–4): This instrument is used by care provider facilities, ORR contractor staff, and ORR Federal staff to process recommendations and decisions for release of a UAC from ORR custody. 4. Safety and Well-Being Follow-Up Call Report (Form R–6): This instrument is used by care provider facilities to document the outcome of calls made to UAC and their sponsors after release to ensure the child is safe and refer the sponsor to additional resources as needed. Respondents: ORR grantee and contractor staff; and released children and sponsors. ANNUAL BURDEN ESTIMATES Annual total number of respondents jbell on DSKJLSW7X2PROD with NOTICES Instrument Annual total number of responses per respondent Average burden minutes per response Annual total burden minutes Discharge Notification (Form R–2) .............................................................. Notice to ICE Chief Counsel—Release of Unaccompanied Alien Child to Sponsor and Request to Change Address (Form R–3) .......................... Release Request (Form R–4) ..................................................................... Safety and Well-Being Follow Up Call Report (R–6) .................................. 206 416 7 599,872 206 206 206 377 356 354 3 45 30 232,986 3,300,120 2,187,720 Estimated Annual Burden Total: .......................................................... ........................ ........................ .......................... 6,320,698 Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the VerDate Sep<11>2014 20:45 Jul 23, 2020 Jkt 250001 use of automated collection techniques or other forms of information technology. Authority: 6 U.S.C. 279; 8 U.S.C. 1232; Flores v. Reno Settlement Agreement, No. CV85–4544–RJK (C.D. Cal. 1996). John M. Sweet Jr., ACF/OPRE Certifying Officer. [FR Doc. 2020–16053 Filed 7–23–20; 8:45 am] Frm 00048 Fmt 4703 Administration for Children and Families Expedited OMB Review and Public Comment; Proposed Information Collection Activity; Services Provided to Unaccompanied Alien Children Office of Refugee Resettlement, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: BILLING CODE 4184–45–P PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Sfmt 4703 E:\FR\FM\24JYN1.SGM 24JYN1

Agencies

[Federal Register Volume 85, Number 143 (Friday, July 24, 2020)]
[Notices]
[Pages 44894-44895]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16030]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel (SEP) meeting on ``COVID-19 REVISION 
SUPPLEMENT APPLICATION ZHS1 HSR-0 (03) HEALTHCARE SYSTEMS & VALUE 
RESEARCH (HSVR).'' This SEP meeting will be closed to the public.

DATES: August 7, 2020.

ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT:  Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly-scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in particular review meetings which require their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2, section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications 
for the ``COVID-19 REVISION SUPPLEMENT APPLICATION ZHS1 HSR-0 (03) 
HEALTHCARE SYSTEMS & VALUE

[[Page 44895]]

RESEARCH (HSVR)'' are to be reviewed and discussed at this meeting. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: July 20, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-16030 Filed 7-23-20; 8:45 am]
BILLING CODE 4160-90-P